Angitia Biopharmaceuticals (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- May 30, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $120,000,000
Company Info
- Company Description
- Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases.
- Market
- Musculoskeletal diseases
- Location
- Woodland Hills, California, USA
- Coinvestors
- Janus Henderson, OrbiMed, 3H Health Investment, Yonghua Capital, Legend Capital, Elikon Venture